CN102266422A - 治疗轻度、重度冻疮的中药制剂及其生产方法 - Google Patents
治疗轻度、重度冻疮的中药制剂及其生产方法 Download PDFInfo
- Publication number
- CN102266422A CN102266422A CN2011101951706A CN201110195170A CN102266422A CN 102266422 A CN102266422 A CN 102266422A CN 2011101951706 A CN2011101951706 A CN 2011101951706A CN 201110195170 A CN201110195170 A CN 201110195170A CN 102266422 A CN102266422 A CN 102266422A
- Authority
- CN
- China
- Prior art keywords
- chilblain
- severe
- chinese medicinal
- medicinal preparation
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000010445 Chilblains Diseases 0.000 title claims abstract description 74
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 238000004519 manufacturing process Methods 0.000 title claims description 17
- 206010008528 Chillblains Diseases 0.000 title abstract description 5
- 239000003814 drug Substances 0.000 claims abstract description 61
- 239000002674 ointment Substances 0.000 claims abstract description 17
- 239000007921 spray Substances 0.000 claims abstract description 14
- 229940040145 liniment Drugs 0.000 claims abstract description 11
- 239000000865 liniment Substances 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- 241000628997 Flos Species 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 239000002994 raw material Substances 0.000 claims description 17
- 239000002671 adjuvant Substances 0.000 claims description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- 230000001737 promoting effect Effects 0.000 claims description 15
- 239000000047 product Substances 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 238000010298 pulverizing process Methods 0.000 claims description 9
- 238000012856 packing Methods 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 239000003623 enhancer Substances 0.000 claims description 3
- 239000003349 gelling agent Substances 0.000 claims description 3
- 230000035876 healing Effects 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 239000008020 pharmaceutical preservative Substances 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 239000002480 mineral oil Substances 0.000 claims description 2
- 235000010446 mineral oil Nutrition 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 229940126680 traditional chinese medicines Drugs 0.000 claims description 2
- 208000002193 Pain Diseases 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 11
- 230000008961 swelling Effects 0.000 abstract description 11
- 238000010792 warming Methods 0.000 abstract description 9
- 208000025865 Ulcer Diseases 0.000 abstract description 8
- 230000036269 ulceration Effects 0.000 abstract description 6
- 230000003213 activating effect Effects 0.000 abstract description 4
- 244000020518 Carthamus tinctorius Species 0.000 abstract description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 240000004064 Poterium sanguisorba Species 0.000 abstract 1
- 235000008291 Poterium sanguisorba Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000003152 Rhus chinensis Species 0.000 abstract 1
- 235000014220 Rhus chinensis Nutrition 0.000 abstract 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract 1
- 230000000740 bleeding effect Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 25
- 210000004369 blood Anatomy 0.000 description 21
- 230000017531 blood circulation Effects 0.000 description 12
- 230000006870 function Effects 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 8
- 230000023597 hemostasis Effects 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 5
- 229920000742 Cotton Polymers 0.000 description 5
- 239000000470 constituent Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 206010040943 Skin Ulcer Diseases 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 4
- 239000010238 camphora Substances 0.000 description 4
- 229940025250 camphora Drugs 0.000 description 4
- 239000004202 carbamide Substances 0.000 description 4
- 235000013877 carbamide Nutrition 0.000 description 4
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 231100000957 no side effect Toxicity 0.000 description 4
- 231100000019 skin ulcer Toxicity 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 3
- 240000008384 Capsicum annuum var. annuum Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 208000001034 Frostbite Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- SDOFMBGMRVAJNF-KVTDHHQDSA-N (2r,3r,4r,5r)-6-aminohexane-1,2,3,4,5-pentol Chemical compound NC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SDOFMBGMRVAJNF-KVTDHHQDSA-N 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 241000717739 Boswellia sacra Species 0.000 description 2
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 2
- QIIDATRCGITYRZ-UHFFFAOYSA-N Catalpol Natural products OCC1OC(OC2OC=CC3C(O)C(=C(CO)C23)O)C(O)C(O)C1O QIIDATRCGITYRZ-UHFFFAOYSA-N 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 208000009084 Cold Injury Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 239000004863 Frankincense Substances 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 229930190125 Sanguisorbin Natural products 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- WCHBFWOEFOZHMK-MLHVESHNSA-N [(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1r,2r,4as,6ar,6as,6br,8ar,10s,12ar,14bs)-1-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-10-[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-ca Chemical compound O([C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@]1(CC[C@H]([C@@]([C@H]14)(C)O)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O WCHBFWOEFOZHMK-MLHVESHNSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 229960002903 benzyl benzoate Drugs 0.000 description 2
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 2
- 235000000431 campesterol Nutrition 0.000 description 2
- LHDWRKICQLTVDL-PZYDOOQISA-N catalpol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2[C@@]3(CO)O[C@H]3[C@@H](O)[C@@H]2C=CO1 LHDWRKICQLTVDL-PZYDOOQISA-N 0.000 description 2
- UXSACQOOWZMGSE-UHFFFAOYSA-N catalposide Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(OC(=O)C=3C=CC(O)=CC=3)C2C=CO1 UXSACQOOWZMGSE-UHFFFAOYSA-N 0.000 description 2
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 2
- 229940117916 cinnamic aldehyde Drugs 0.000 description 2
- WJSDHUCWMSHDCR-VMPITWQZSA-N cinnamyl acetate Natural products CC(=O)OC\C=C\C1=CC=CC=C1 WJSDHUCWMSHDCR-VMPITWQZSA-N 0.000 description 2
- 230000002595 cold damage Effects 0.000 description 2
- 229960000956 coumarin Drugs 0.000 description 2
- 235000001671 coumarin Nutrition 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000010642 eucalyptus oil Substances 0.000 description 2
- 229940044949 eucalyptus oil Drugs 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- LHDWRKICQLTVDL-UHFFFAOYSA-N methyl iridoid glycoside Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(O)C2C=CO1 LHDWRKICQLTVDL-UHFFFAOYSA-N 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000003119 painkilling effect Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 210000002356 skeleton Anatomy 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 235000010894 Artemisia argyi Nutrition 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- PGTJIOWQJWHTJJ-CHWSQXEVSA-N Calamenene Chemical compound C1=C(C)C=C2[C@@H](C(C)C)CC[C@@H](C)C2=C1 PGTJIOWQJWHTJJ-CHWSQXEVSA-N 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 1
- 241000208809 Carthamus Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 235000008597 Diospyros kaki Nutrition 0.000 description 1
- 206010049927 Dry gangrene Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241000269799 Perca fluviatilis Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 235000019057 Raphanus caudatus Nutrition 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000011380 Raphanus sativus Nutrition 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010044604 Trichiasis Diseases 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 241000949456 Zanthoxylum Species 0.000 description 1
- 244000089698 Zanthoxylum simulans Species 0.000 description 1
- CGDNTCPMNAKDJB-MUBDFRAASA-N [C@@H]12CC(C)=CC[C@H]1C(C)=CC[C@H]2C(C)C.[C@@H]21CC(C)=CC[C@H]2C(C)=CC[C@H]1C(C)C Chemical compound [C@@H]12CC(C)=CC[C@H]1C(C)=CC[C@H]2C(C)C.[C@@H]21CC(C)=CC[C@H]2C(C)=CC[C@H]1C(C)C CGDNTCPMNAKDJB-MUBDFRAASA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 244000030166 artemisia Species 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 238000004380 ashing Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- PAYPBTPGBHRBLY-UHFFFAOYSA-N calamenene Natural products C1=CC(C)=CC2C(C(C)C)CCC(C)C21 PAYPBTPGBHRBLY-UHFFFAOYSA-N 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 125000002871 cinnamic aldehydes group Chemical group 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000027950 fever generation Effects 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000009746 freeze damage Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000010201 sheng-ji-san Substances 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-N sorbic acid group Chemical group C(\C=C\C=C\C)(=O)O WSWCOQWTEOXDQX-MQQKCMAXSA-N 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- PGTJIOWQJWHTJJ-UHFFFAOYSA-N trans-Calamenene Natural products C1=C(C)C=C2C(C(C)C)CCC(C)C2=C1 PGTJIOWQJWHTJJ-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗治疗轻度、重度冻疮的中药制剂,它的有效成分是川椒、桂枝、生地、红花、地榆和五倍子,将药物提取有效成分后做成外用涂抹剂或喷剂,或者做成药膏,具有温经散寒,治血通络,益气补阳,消肿止痛的功能,轻度冻疮用药后1-2次,24小时内能够治愈,重症破溃冻疮72-96个小时内用药3-5次即可治愈,总有效率达98%以上,无副作用。
Description
技术领域
本发明涉及一种中药制剂,一种治疗轻度、特别是重度冻疮的中药制剂及其生产方法。
背景技术
冻疮是由人体受寒邪侵袭,气血瘀滞引起的皮肤损伤,好发于手、足、耳廓及鼻尖等处。中医亦称为“冻烂疮”。是冬天极为常见的皮肤病。是由于冬季气候寒冷,外露的皮肤受到冷冻的刺激,时间一长,皮下小动脉发生痉挛收缩。产生血液瘀滞,使局部组织缺氧,重度冻疮可伤及肌肉、骨骼和器官,导致生命危险。一般冻疮的临床分度如下:
Ⅰ度(红斑性冻疮):皮肤从白变成红色,出现明显的红肿,自觉疼痛或作痒。
Ⅱ度(水疱性冻疮):早期有红肿,继而出现大小不一的水疱,有不同程度的疼痛。
Ⅲ度(坏死性冻疮):轻者在伤后3-7天出现水疱,可延及整个肢体或全身,活动受限制,病变部位呈紫黑色,周围水肿,并有明显疼痛。重者肌肉、骨骼均有冻伤,呈干性坏疽,患部感觉和机能完全丧失。2-3周后,出现冻伤组织与健康组织的分界线。如有染毒腐溃,可呈现湿性坏疽。
冻疮治疗目前有很多方法,我国民间很早就知道治疗冻疮有用萝卜、生姜、柿子皮、大蒜、辣椒等擦受冻害的皮肤表面;一些资料报道,可以采用以下的方法治疗冻疮,轻度冻疮:1、用伤湿止痛膏外贴患处;2、用萝卜皮煎水外洗;3、当归、肉桂各6克,川椒、红花、细辛、干姜各3克,用75%的酒精100毫升浸泡一周后外用。每天早中晚洗手后用棉签蘸药液涂患处,并揉揉至局部发热,连续治一周即愈。重度冻疮:1、苦楝子30克水煎外洗患处,然后用猪蹄壳3个烧灰研末调香油敷患处。、陈石灰30克,冰片3克,研匀撒患处。3.5%硼酸软膏外敷。3、患部溃烂处新生时,可用红油膏掺生肌散外敷。方法二:内服中药 方剂:当归15克,桂枝、赤芍、大枣各10克,生姜、甘草各5克,水煎服,一日一剂,有温经散寒,治血通络,消肿止痛之效。此方在冻疮未生时用,可免生冻疮,红肿未溃者用,可促肿消痛止;破溃者用,可使溃疡处早日愈合。
有关治疗冻疮的专利文献报道比较多,以下我们列出部分作为本发明的背景技术参考:
1、中国专利,名称:一种预防和治疗冻疮的中药 申请(专利)号:CN200610125153.4申请日:2006.11.25 公开(公告)号:CN101015625 公开(公告)日:2007.08.15 申请(专利权)人:刘承林 地址:湖北省荆门市掇刀区人民医院 发明(设计)人:刘承林 摘要:一种预防和治疗冻疮的中药,它由生川乌、生草乌、辣椒、桂枝、芒硝、红花、细辛、樟脑、甘油、酒精组成;其重量份配比为:生川乌20-100 生草乌20-100 辣椒20-100 桂枝10-80 芒硝10-80 红花10-30 细辛10-30 樟脑2-8 甘油100-300浓度为75%的酒精500-2000。优点是:它具有祛风散寒、活血通经、消肿止痛、润肤护肤的功能,预防和治疗冻疮的效果好,见效快,生产成本较低。
2、中国专利,名称:治疗冻疮中草药 申请(专利)号:CN02138178.X 申请日:2002.08.24,公开(公告)号:CN1408421,公开(公告)日:2003.04.09 申请(专利权)人:宋国州,地址:江苏省新沂市钟吾路155号农机局大楼三楼,发明(设计)人:宋国州,摘要:一种治疗冻疮中草药,该药由九种中草药组成,按药物重量百分比为生黄芪18%、嫩桂枝18%、全当归18%、紫油桂9%、片干姜9%、西红花9%、大川椒9%、北细辛5%、潮脑5%,将上述中草药除去杂质后,烘干,再破碎进行搅拌混合,然后放入缸坛中,按1公斤药物加入4000毫升95%的酒精的比例,向缸坛中注入95%酒精,密封缸坛,浸泡药物8个昼夜后开封缸坛,滤除药渣取净药液用于治疗冻疮。无任何毒副作用及过敏反应,人身各个部位的冻疮均宜使用,适应于各种非溃烂型及溃烂型冻疮的治疗,特别是对溃烂型冻疮的溃疡面的早期修复,疗效显著,缩短了治疗时间,对于各种类型的冻疮的有效率及治愈率均在97%以上。
3、中国专利,名称:当归艾叶冻疮汤,申请(专利)号:CN200710022309.0 申请日:2007.05.11,公开(公告)号:CN101049490公开(公告)日:2007.10.10 申请(专利权)人:陈江,地址:江苏省吴江市松陵镇鲈乡二区11栋401室,发明(设计)人:陈江,摘要:一种冻疮汤,以当归、桂枝、赤芍、细辛、通草、甘草、大枣、红花、川椒、防风、荆芥、艾叶、乳香、生姜、甘草、白矾、樟脑为原料,具有温经散寒、活血化淤、消肿止痛的功效,对治疗和预防冻疮疗效显著。主权项:1.一种冻疮汤,其特征在于由以下配方配比组成:当归、桂枝、赤芍、细辛、通草、甘草、大枣各30克,红花、川椒、防风、荆芥、艾叶、乳香20克,生姜、甘草、白矾、樟脑15克为原料,加清水适量,煮沸10分钟,将药液倒入盆内,手足熏洗后浸泡患处。
从上述检索资料看,目前治疗冻疮的主要中药是,其主要功能是祛风散寒、活血通经、消肿止痛、润肤护肤的药物,以改善血液循环、温经散寒,治血通络,消肿止痛。但是,对于重度冻伤造成的溃烂型冻疮的治疗效果还不是十分理想。
发明内容
本发明人针对冻疮的发生,运用中医药理论优选了一些中药,做成一种活血化瘀、消肿止痛、解毒敛疮、润泽护肤的药物,能够在初期冻疮药后24小时内治愈,重症破溃冻疮72-96个小时内治愈。总有效率达100%,无副作用,恢复后皮肤保持正常。
本发明治疗轻度、重度冻疮的中药制剂的有效成分是由以下重量份数的中药原料制成的:
川椒:15-30;
桂枝:15-30;
生地:15-30;
红花:3-10;
地榆:15-30;
五倍子:8-15。
本发明治疗轻度、重度冻疮的中药制剂可以做成外用涂抹剂或喷剂,或者做成药膏,其生产方法如下:
1、涂抹剂(水剂)或喷剂
以上中药原料先经粗粉碎,再按药物原料总重量加水15-20倍,煮沸0.5-1小时,滤过,药渣按重量加水15-20倍,煮沸0.5小时,滤过,合并两次滤液,浓缩至合并两次总滤液量体积的50%,加入适量药用防腐剂,灌装到药瓶或喷雾瓶,灭菌,得到药液成品。
所述的药用防腐剂是山梨酸、苯甲酸钠、抗坏血酸等。
2、药膏
以上中药原料先经粗粉碎,再按药物原料总重量加水15-20倍,煮沸0.5-1小时,滤过,药渣按重量加水15-20倍,煮沸0.5小时,滤过,合并两次滤液,浓缩至相对密度为1.32~1.35(60℃)的稠膏,加入辅料,辅料与的稠膏重量比,辅料为70-30%,稠膏为30-70%,适当加热到50-70℃,混合均匀,做成膏状,包装,得到成品。
所述的辅料包括溶剂、胶凝剂、促愈合增效剂、表面活性剂、皮肤透皮吸收促进剂等。
所述溶剂包括:水、乙醇、丙二醇、矿物油、甘油、山梨醇和醋酸乙酯。
所述的胶凝剂包括:卡波姆、壳聚糖、聚乙烯醇、硬酯酸、聚乙二醇和羧甲基纤维素等。
所述的促愈合增效剂包括:尿囊素、维生素、透明质酸和抗坏血酸。
所述的表面活性剂包括:吐温、司盘、月桂酸、棕榈酸、硬酯酸和十二烷基硫酸钠。
所述的皮肤透皮吸收促进剂可以包括:乙醇、丙二醇、尿素、桉叶油和松节油等。
本发明的治疗轻度、重度冻疮的中药制剂具有:消肿、止痛、止痒、活血化瘀、散结生新的功能。
用量用法:
1、涂抹剂或喷剂,用棉签沾上药液涂抹到受到轻度冻疮的皮肤表面,重度的冻疮可以用喷剂喷到冻疮的皮肤表面。
2、药膏,用棉签沾上药膏涂抹到受到轻度冻疮的皮肤表面,重度的冻疮可以将纱布涂上药膏,然后轻轻包裹患处。
涂抹剂和可以按药液与水的体积比45℃温水(1∶5-10),用于手、足冻疮浸泡20分钟;或者用手巾沾湿后反复擦洗患处10分钟即可。每天早、晚各疗用一次。轻度冻疮用药后1-2次,24小时内能够治愈,重症破溃冻疮72-96个小时内用药3-5次能够治愈。总有效率达98%以上,无毒副作用。
以下是本发明各药物的学名、功效。
【川椒】拉丁学文(Zanthoxylumbungeanum)。别名:大椒、秦椒、南椒、巴椒等,川椒隶属于芸香科、花椒属,果球形,通常2-3个,果球颜色大多为青色,红色,紫红色或者紫黑色,密生疣状凸起的油点。性味:辛;性温;小毒。归经:脾经;肺经;肝经;肾经;心经;心包经。功能:温中止痛;除湿止泻;杀虫止痒。主治:脾胃虚寒之脘腹冷痛;蛔虫腹痛;呕吐泄泻;肺寒咳喘;肺寒咳喘;龋齿牙痛;阴痒带下;湿疹皮肤瘙痒。
【桂枝】拉丁学文(Ramulus Cinnamomi)化学成分:桂枝含挥发油0.69%,油中主要成分为桂皮醛(cinnamaldehyde)64.75%,还有苯甲酸苄酯(benzylbenzoate),乙酸肉桂酯(cinnamylacetate),β-荜澄茄烯(β-cadinene),菖莆烯(calamenene),香豆精(coumarin)等。功用主治:散寒解表;温通经脉;通阳化气。
【生地】,生地黄,拉丁学文(Radix Rehmanniae)化学成分:含梓醇(catalpol)、多种氨基酸和糖、甘露醇、β-谷甾醇及菜油甾醇(campesterol)等。功能主治:鲜地黄清热生津,凉后,止血;用于热风伤阴、舌绛烦渴、发斑发疹、吐血、衄血、咽喉肿痛。生地黄清热凉血,养阴,生津;用于热病烦渴、发斑发疹、阴虚内热、吐血、衄血、糖尿病、传染性肝炎。
红花,英文名Safflower,菊科植物红花Carthamus tinetorius L.的管状花。红花的功效:功能主治活血通径、散瘀止痛。用于经闭、痛经、恶露不行、症瘕痞块、跌打损伤。古人常有於血在体内时,常加红花一小把:纱布包煮开可用一天两次泡脚,适用各种静脉曲张,末梢神经炎,血液循环。活血能经;祛瘀止痛,红花味辛、性温,归心、肝经。气香行散,入血分具有活血通经,祛瘀止痛的功效主治痛经,经闭,产后血晕,瘀滞腹痛,胸痹心痛,血积,跌打瘀肿,关节疼痛,中风瘫痪,斑疹紫暗。
【地榆】拉丁学文(Radix Sanguisorbae)化学成分:含地榆甙i、ii(ziyu-glycosidei,ii)、地榆皂甙a、b、e(sanguisorbin a,b,e)和没食子酸、鞣质等。功用主治:凉血止血,解毒敛疮。用于便血、痔血、血痢、崩漏、水火烫伤、痈肿疮毒。
【五倍子】拉丁学文(Galla Chinensis)化学成分:盐肤木虫瘿含大量五倍子鞣酸及树脂、脂肪、淀粉。功用主治:敛肺,涩肠,止血,解毒。治肺虚久咳,久痢。久泻,脱肛,目汗,盗汗,遗精,便血,衄血,崩漏,外伤出血,肿毒,疮疖,睫毛倒卷。
在中医学上来说,由于冻疮患者大多体质阳虚,故气血运行不畅,凝滞脉络,久而久之肌肤便会失去养分,导致阴寒久伏于脉络,因此,冻疮会反复发生。所以针对冻疮病理特点,采用温中止痛;除湿止泻的川椒。红花助丹参活血行气、化瘀通络;桂枝散寒解表、温通经脉、通阳化气;大黄攻积导滞、化被散结;地榆凉血止血,解毒敛疮,生地清热生津,凉血,止血;五倍子敛肺,涩肠,止血,解毒,具有改善微循环的作用。本发明紧扣冻疮之病因病机,多法联用,温经散寒,治血通络,益气补阳,消肿止痛。标本兼治,且结合现代医学研究成果,针对性地选药组方,在症状体征、皮肤的改善及血液流畅方面取得显著疗效。
本发明与现有技术相比,其突出的实质性特点和显著的进步是:
(1)本发明药物性微温,活血散瘀,消肿止痛,轻度冻疮用药后(1-2次)24小时内能够治愈,重症破溃冻疮72-96个小时内用药(3-5次)能够治愈。总有效率达98%以上,无副作用。
(2)本发明的治疗冻疮的中药制剂遵循了祖国医学整体现念和辨证施治原则,从理论上研究探讨中风及其后遗症发生发展的规律,并采用活血化瘀、软坚散结、清热解毒、扶正培本等具有中医药特色的“作战”手段,做到“用药如用兵”,才能“知己知彼,百战百胜”。
(3)组方科学,生产工艺先进,可操作性强,产品价格适中,适合工业化生产。
(4)生产中根据各味中药原料的有效成分性质及制剂要求,制成水剂、膏剂,因而产品有效成分含量高,且不易变质,保存期长。
(5)本发明的产品急性毒性研究及长期毒性研究的结果表明,按拟用日剂量疗程外用,使用本发明产品是安全的。
具体实施方式
以下是本发明的实施例:
实施例1、
涂抹剂(水剂)的生产,原料:川椒:150g;桂枝:150g;生地:150g;红花:30g;地榆:150g;五倍子:80g。
以上中药原料先经粗粉碎,再按药物原料总重量加水20倍,煮沸1小时,滤过,药渣按重量加水15倍,煮沸0.5小时,滤过,合并两次滤液,浓缩至合并两次总滤液量体积的50%,加入10g山梨酸,灌装到药瓶,灭菌,得到涂抹剂(水剂)药液成品。
实施例2、
喷雾剂的生产,原料:川椒:200g;桂枝:200g;生地:200g;红花:50g;地榆:200g;五倍子:100g。
以上中药原料先经粗粉碎,再按药物原料总重量加水20倍,煮沸1小时,滤过,药渣按重量加水16倍,煮沸0.5小时,滤过,合并两次滤液,浓缩至合并两次总滤液量体积的50%,加入10g苯甲酸钠,灌装到喷雾瓶,灭菌,得到喷雾剂药液成品。
实施例3、
冻疮药膏的生产:原料,川椒:250g;桂枝:250g;生地:250g;红花:80g;地榆:250g;五倍子:120g。
以上中药原料先经粗粉碎,再按药物原料总重量加水15-20倍,煮沸0.5-1小时,滤过,药渣按重量加水15-20倍,煮沸0.5小时,滤过,合并两次滤液,浓缩至相对密度为1.32~1.35(60℃)的稠膏,加入甘油、10g,硬酯酸10g,抗坏血酸10g,尿素10g,辅料与的稠膏重量比,辅料为70-30%,稠膏为30-70%,适当加热到50-70℃,混合均匀,做成膏状,包装,得到成品。
实施例4
冻疮药膏的生产:原料,川椒:300g;桂枝:300g;生地:300g;红花:100g;地榆:300g;五倍子:150g。
以上中药原料先经粗粉碎,再按药物原料总重量加水15-20倍,煮沸0.5-1小时,滤过,药渣按重量加水15-20倍,煮沸0.5小时,滤过,合并两次滤液,浓缩至相对密度为1.32~1.35(60℃)的稠膏,加入辅料:丙二醇10g,吐温80 10g,抗坏血酸10g,尿素10g,醋酸乙酯10g,水50g,辅料与的稠膏重量比,辅料为70-30%,稠膏为30-70%,适当加热到50-70℃,混合均匀,做成膏状,包装,得到成品。
实施例5
川椒:15-30;桂枝:15-30;生地:15-30;红花:3-10;地榆:15-30;五倍子:8-15
冻疮药膏的生产:原料,川椒:200g;桂枝:200g;生地:250g;红花:60g;地榆:250g;五倍子:120g。
以上中药原料先经粗粉碎,再按药物原料总重量加水15-20倍,煮沸0.5-1小时,滤过,药渣按重量加水15-20倍,煮沸0.5小时,滤过,合并两次滤液,浓缩至相对密度为1.32~1.35(60℃)的稠膏,加入辅料:乙醇(70%含量)10g,吐温80 10g,壳聚糖10g,尿素10g,聚乙烯醇10g,水50g,桉叶油,辅料与的稠膏重量比,辅料为70-30%,稠膏为30-70%,适当加热到50-70℃,混合均匀,做成膏状,包装,得到成品。
本发明本发明治疗轻度、重度冻疮的中药制剂的临床研究报告:
本品是经验方,经5年来对100例轻度、重度冻疮患者的临床应用,其有效率达98%以上,治愈达95%。
轻度、重度冻疮的中药制剂于2006年开始临床实践至2010年,总临床验证如下:
轻度冻疮80人;重度冻疮20人。
轻度冻疮采用涂抹剂或喷剂,用棉签沾上药液涂抹到受到轻度冻疮的皮肤表面。
重度的冻疮用药膏,将纱布涂上药膏,然后轻轻包裹患处。
每天早、晚各疗用一次。轻度冻疮大多数用药1-2次后,24小时内能够治愈,重症破溃冻疮用药3-5次,一般72-96个小时内能够治愈。总有效率达98%以上,无毒副作用。
病例1:
广西桂林市郊区菜农张**,女36岁。2010年2月20日就诊,手上长冻疮,肿得像馒头,采用涂抹剂,用棉签沾上药液涂抹到皮肤表面,用药2次,2天后痊愈,无后遗症。
病例2:
广西全州市韦某,男,45岁,户外电工。2008年2月,在室外抢修被大雪压住的高压线路,手脚均长冻疮,用药膏,将纱布涂上药膏,包裹患处,用药4次后痊愈,后遗症。
病例3:
广西柳州市黄某,女,4岁,2011年2月由于经不起寒冷,耳朵,手上均长冻疮,特别是耳朵,已经有轻度溃烂,后用采用喷剂,将药液喷到冻疮的皮肤表面。反复用药3天后痊愈,无后遗症。
Claims (4)
1.一种治疗轻度、重度冻疮的中药制剂,其特征在于:它的有效成分是由以下重量份数的中药原料制成的:
川椒:15-30;
桂枝:15-30;
生地:15-30;
红花:3-10;
地榆:15-30;
五倍子:8-15;
所述的中药制剂是外用涂抹剂或喷剂,或者做成药膏。
2.根据权利要求1所述的治疗轻度、重度冻疮的中药制剂,其特征在于:外用涂抹剂或喷剂的生产方法如下:
先将川椒、桂枝、生地、红花、地榆、五倍子经粗粉碎,再按药物原料总重量加水15-20倍,煮沸0.5-1小时,滤过,药渣按重量加水15-20倍,煮沸0.5小时,滤过,合并两次滤液,浓缩至合并两次总滤液量体积的50%,加入适量药用防腐剂,灌装到药瓶或喷雾瓶,灭菌,得到药液成品。
3.根据权利要求1所述的治疗轻度、重度冻疮的中药制剂,其特征在于:药膏的生产方法如下:
先将川椒、桂枝、生地、红花、地榆、五倍子经粗粉碎,再按药物原料总重量加水15-20倍,煮沸0.5-1小时,滤过,药渣按重量加水15-20倍,煮沸0.5小时,滤过,合并两次滤液,浓缩至60℃时相对密度为1.32~1.35的稠膏,加入辅料,辅料与的稠膏重量比,辅料为70-30%,稠膏为30-70%,适当加热到50-70℃,混合均匀,做成膏状,包装,得到成品。
4.根据权利要求1所述的治疗轻度、重度冻疮的中药制剂,其特征在于:所述的辅料包括溶剂、胶凝剂、促愈合增效剂、表面活性剂和皮肤透皮吸收促进剂。
所述溶剂包括:水、乙醇、丙二醇、矿物油、甘油、山梨醇和醋酸乙酯。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101951706A CN102266422A (zh) | 2011-07-13 | 2011-07-13 | 治疗轻度、重度冻疮的中药制剂及其生产方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101951706A CN102266422A (zh) | 2011-07-13 | 2011-07-13 | 治疗轻度、重度冻疮的中药制剂及其生产方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102266422A true CN102266422A (zh) | 2011-12-07 |
Family
ID=45049004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011101951706A Pending CN102266422A (zh) | 2011-07-13 | 2011-07-13 | 治疗轻度、重度冻疮的中药制剂及其生产方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102266422A (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103340969A (zh) * | 2013-07-19 | 2013-10-09 | 苏州市天灵中药饮片有限公司 | 一种治疗冻伤的中药的制备方法 |
CN103385959A (zh) * | 2013-07-19 | 2013-11-13 | 苏州市天灵中药饮片有限公司 | 一种治疗冻伤的中药配方 |
CN103860752A (zh) * | 2012-12-16 | 2014-06-18 | 王宝燕 | 一种治冻疮药膏 |
CN104056114A (zh) * | 2014-07-18 | 2014-09-24 | 郑志保 | 一种治疗冻疮的中药制剂 |
CN106421073A (zh) * | 2016-12-18 | 2017-02-22 | 张永红 | 一种治疗冻疮的药物及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1408421A (zh) * | 2002-08-24 | 2003-04-09 | 宋国州 | 治疗冻疮中草药 |
-
2011
- 2011-07-13 CN CN2011101951706A patent/CN102266422A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1408421A (zh) * | 2002-08-24 | 2003-04-09 | 宋国州 | 治疗冻疮中草药 |
Non-Patent Citations (4)
Title |
---|
《吉林农业》 19940220 李长林 家畜冻伤治疗验方九则 , 第02期 * |
《广西中医药》 19811220 李家强 冻疮 , 第06期 * |
《老友》 20080201 祁增年 治冻疮单方四则 , 第02期 * |
《老友》 20080201 祁增年 治冻疮单方四则 , 第2期 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103860752A (zh) * | 2012-12-16 | 2014-06-18 | 王宝燕 | 一种治冻疮药膏 |
CN103340969A (zh) * | 2013-07-19 | 2013-10-09 | 苏州市天灵中药饮片有限公司 | 一种治疗冻伤的中药的制备方法 |
CN103385959A (zh) * | 2013-07-19 | 2013-11-13 | 苏州市天灵中药饮片有限公司 | 一种治疗冻伤的中药配方 |
CN104056114A (zh) * | 2014-07-18 | 2014-09-24 | 郑志保 | 一种治疗冻疮的中药制剂 |
CN106421073A (zh) * | 2016-12-18 | 2017-02-22 | 张永红 | 一种治疗冻疮的药物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103041173B (zh) | 一种治疗皮炎、湿疹的中药外用制剂及其制备方法 | |
CN101455738B (zh) | 一种治疗湿疹的中药组合物及其制备方法 | |
CN104306514A (zh) | 一种中药喷剂及其制备方法 | |
CN104208245B (zh) | 手足癣中药药浴及制备方法 | |
CN101401860A (zh) | 一种治疗皮肤病的外用药物组合物 | |
CN102106941B (zh) | 治疗痔疮的中药制剂及其制备方法 | |
CN102266422A (zh) | 治疗轻度、重度冻疮的中药制剂及其生产方法 | |
CN101391015A (zh) | 治疗复发性痔疮的外用中药散剂 | |
CN100404054C (zh) | 一种煮散型中药抗菌消炎剂及其制备方法和应用 | |
CN101584849B (zh) | 一种用于治疗经前期紧张综合症的复方当归川芎汤 | |
CN101167991A (zh) | 治疗烧烫伤的药膏 | |
CN102908391A (zh) | 一种治疗皮肤病的中药组合物及其制备方法和应用 | |
CN106421392A (zh) | 一种治疗褥疮的中药凝胶剂及其制备方法 | |
CN1318052C (zh) | 一种治疗痤疮的药物组合物及制备方法 | |
CN102068676A (zh) | 一种治疗冻疮的药物 | |
CN106377604A (zh) | 一种抗菌消炎止痒中药软膏及其制备方法 | |
CN105535502A (zh) | 一种治疗成人牙周炎的中药制剂及其制备方法 | |
CN113663049B (zh) | 一种黎药产后药浴泡腾颗粒及其制备方法 | |
CN102872289B (zh) | 一种治疗慢性胃炎的中药组合物及其制备方法 | |
CN102228661B (zh) | 一种治疗慢性胆囊炎的中药合剂 | |
CN106620140A (zh) | 一种治疗水牛腐蹄病的中药组合物 | |
CN107551030B (zh) | 一种抗静脉血栓形成的中药组合物、制剂及制备方法 | |
CN105125926A (zh) | 用于治疗烧烫伤的药粉及制备方法 | |
CN105560582A (zh) | 治疗冻疮的消肿止痒药膏及制法 | |
CN104208360A (zh) | 瘙痒性湿疹中药药浴及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20111207 |